A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT01334918
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT01334918
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01334918. Randomized; no masking; primary purpose diagnostic. Start 2011-04-26 (actual); primary completion 2012-07-02 (actual). Results posted on 2013-09-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
- Intervention (Drug)
- regadenoson
- Intervention (Radiation)
- technetium Tc99m sestamibi /technetium Tc99m tetrafosmin
- Intervention (Radiation)
- Contrast
- Intervention (Procedure)
- Single Photon Emission Computed Tomography
- Intervention (Procedure)
- Multidetector Computed Tomography
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01334918- Content hash
7fdf004e46ac9f62805d6bba6e14f4bb685e8580aaa220da330c0f4bb207f0eb